5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
India
The Asia Pacific Genetic Testing Market is Segmented by Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, Other Types), Disease, Technology, and Geography.
Study Period:
2017-2025
Base Year:
2020
CAGR:
11 %
The Asia-Pacific Genetic Testing market was expected to grow with a CAGR of 11.0%. Certain factors that are driving the market growth include a growing demand for personalized medicine and the increased application of genetic testing in oncology.
The FDA has approved several drugs for the treatment of lung cancer. Genetic discoveries over the past decade have transformed the way doctors treat and interpret this disease. Personalized medicine and genetic services play a vital role in wellness, prevention, and selection of cost-saving therapy.
The diagnostic and pharmaceuticals sector in the Asia-Pacific region has gained momentum, owing to speedy adoption and rising technological advancements. This has resulted in the adoption of personalized medicine across the region, including the creation of a pharmacogenomics research network, across the globe.
A genetic test is a test performed to identify the presence of a particular gene or set of genes, with a particular sequence of the genome. The genes can be identified either directly through sequencing or indirectly through various methods. Genetic testing practices are rapidly increasing in rare disease diagnostics and for personalized medicines, which is driving the growth of this market. Asia-Pacific Genetic Testing Market is segmented By Type, By Disease, By Technology and Geography.
By Type | |
Carrier Testing | |
Diagnostic Testing | |
Newborn Screening | |
Predictive and Presymptomatic Testing | |
Prenatal Testing | |
Other Types |
By Disease | |
Alzheimer's Disease | |
Cancer | |
Cystic Fibrosis | |
Sickle Cell Anemia | |
Duchenne Muscular Dystrophy | |
Thalassemia | |
Huntington's Disease | |
Rare Diseases | |
Other Diseases |
By Technology | |
Cytogenetic Testing | |
Biochemical Testing | |
Molecular Testing |
Geography | ||||||||
|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
The Asia-Pacific genetic testing market is highly competitive and consists of several major players. In terms of market share, a few major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new ingredients at lower prices. Companies like Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Genomic Health Inc., and Mapmygenome hold the substantial market share in the Asia-Pacific genetic testing market.
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Emphasis on Early Disease Detection and Prevention
4.2.2 Growing Demand for Personalized Medicine
4.2.3 Increasing Application of Genetic Testing in Oncology
4.3 Market Restraints
4.3.1 High Costs of Genetic Testing
4.3.2 Social and Ethical Implications of Genetic Testing
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 Carrier Testing
5.1.2 Diagnostic Testing
5.1.3 Newborn Screening
5.1.4 Predictive and Presymptomatic Testing
5.1.5 Prenatal Testing
5.1.6 Other Types
5.2 By Disease
5.2.1 Alzheimer's Disease
5.2.2 Cancer
5.2.3 Cystic Fibrosis
5.2.4 Sickle Cell Anemia
5.2.5 Duchenne Muscular Dystrophy
5.2.6 Thalassemia
5.2.7 Huntington's Disease
5.2.8 Rare Diseases
5.2.9 Other Diseases
5.3 By Technology
5.3.1 Cytogenetic Testing
5.3.2 Biochemical Testing
5.3.3 Molecular Testing
5.4 Geography
5.4.1 Asia-Pacific
5.4.1.1 China
5.4.1.2 Japan
5.4.1.3 India
5.4.1.4 Australia
5.4.1.5 South Korea
5.4.1.6 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 Danaher Corporation (Cepheid)
6.1.4 Genomic Health Inc.
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Illumina Inc.
6.1.7 Mapmygenome
6.1.8 Myriad Genetics Inc.
6.1.9 Qiagen NV
6.1.10 Thermo Fisher Scientific Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments